Nonvalvular Atrial Fibrillation Clinical Trial
Official title:
An Early Evaluation of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation (NVAF) Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin in the US
The overall objective of this proposal is to execute a real-world database analysis to
evaluate hospital readmissions among hospitalized nonvalvular atrial fibrillation (NVAF)
patients in the U.S
Primary objective: To determine the proportions of NVAF patients with bleeding-related
hospital readmissions that occur within 30 days of the hospitalization of NVAF patients
treated with the new oral anticoagulants (NOACs), dabigatran, rivaroxaban, apixaban or
warfarin in the inpatient setting
Secondary objectives:
- To determine the cost associated with bleeding-related hospital readmissions that occur
within 30 days of the hospitalization of NVAF patients treated with dabigatran,
rivaroxaban, apixaban or warfarin in the inpatient setting
- To determine the proportions of NVAF patients with all cause hospital readmissions and
the associated costs that occur within 30 days of the hospitalization of NVAF patients
treated with dabigatran, rivaroxaban, apixaban or warfarin in the inpatient setting.
n/a
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04586972 -
Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
|
||
Completed |
NCT02007655 -
Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
|
||
Recruiting |
NCT04494347 -
Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR)
|
N/A | |
Not yet recruiting |
NCT04942873 -
The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
|
||
Recruiting |
NCT05731882 -
First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder
|
N/A | |
Completed |
NCT01885598 -
Eliquis Regulatory Post Marketing Surveillance
|
N/A | |
Completed |
NCT02919982 -
Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation
|
||
Completed |
NCT00684307 -
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
|
Phase 2 | |
Recruiting |
NCT04073316 -
AntiCoagulants and COGnition
|
Phase 4 | |
Completed |
NCT03374540 -
Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
|
||
Recruiting |
NCT05715658 -
Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects
|
N/A |